Upcoming Financial Results Announcement from Assertio Holdings
Assertio Holdings, Inc. (NASDAQ: ASRT), known for its commitment to deliver innovative solutions in the pharmaceutical sector, is gearing up to announce its second quarter 2025 financial results. The announcement is set for a Monday in August, following the market close. This report will provide essential insights into the company’s performance and strategic direction.
Details of the Financial Disclosure Event
On the announcement day, company management will conduct a live conference call at 4:30 p.m. Eastern Time. This session will be crucial for stakeholders as it will cover the financial results and shed light on the evolving landscape for Assertio's business strategy in 2025.
How to Access the Live Conference Call
Investors wishing to participate should connect at least 10 minutes before the call to ensure a smooth experience. The conference call will also be available for those who prefer to join via telephone; the dialing number provided is +1-646-307-1963 and the call ID to reference is 3278948.
Webcast Replay Availability
A replay of the live conference call will be accessible about two hours post-event on Assertio's investor relations website. This is an excellent opportunity for those who may not be able to attend the live call to catch up on the discussions and insights shared by the management.
About Assertio Holdings, Inc.
Assertio Holdings, Inc. operates as a pharmaceutical entity with a broad spectrum of commercial capabilities. The company's portfolio includes distinctive products tailored to address the needs of patients across various therapeutic areas, especially focusing on oncology, neurology, and pain management. Assertio's mission emphasizes a commitment to improving the quality of life for patients.
For further information about Assertio, including its comprehensive offerings and ongoing initiatives, investors and stakeholders can visit their investor relations portal.
Investor Relations Contact Information
For additional inquiries, investors can reach out to Matt Kreps at Darrow Associates Investor Relations. He can be contacted at +1-214-597-8200 or via email at mkreps@darrowir.com.
Frequently Asked Questions
What is Assertio's main focus in the pharmaceutical industry?
Assertio specializes in providing innovative treatments primarily in oncology, neurology, and pain management, focusing on distinctive pharmaceutical products.
When will Assertio release its financial results?
The financial results for the second quarter of 2025 will be disclosed on August 11, 2025, after the market closes.
How can I join the conference call?
To join the call, dial +1-646-307-1963 and reference the call ID 3278948. Make sure to connect at least 10 minutes early.
Is there a way to listen to the call after it takes place?
Yes, a replay of the conference call will be available approximately two hours after the live event on Assertio's investor relations website.
Who should I contact for investor relations inquiries?
For any investor-related questions, reach out to Matt Kreps at Darrow Associates Investor Relations via phone or email for support.
